Better batteries are needed for the energy transition. To this end, we are developing new types of electrode materials and conducting research with partners in the BMBF project SkaLis. A 360° panorama tour shows the Pouch Cell Laboratory, where the experimental batteries are produced.
Battery research at HZB
Green hydrogen for the energy transition
CatLab in Berlin will become a beacon for research on catalyst materials. Such materials are needed to produce green hydrogen with renewable energy such as sunlight or wind power. Green Hydrogen is considered a building block in a future climate-neutral energy supply. Climate protection and sustainability also played a major role in the architectural competition.
50 years of Protein Data Bank
The Protein Data Bank is celebrating this year the 50th anniversary of its founding as the first freely accessible digital data source for biology. There are three beamlines dedicated to protein crystallography at BESSY II. They can be used to decode the 3D architecture of proteins. Discover more on our page Protein crystallography: a tool for decoding the building blocks of life.
How does BESSY II contribute to the research on SARS-CoV-2?
At the light source BESSY II, researchers gain important insights into the corona virus. How do they do that? Our expert Manfred Weiss explains on the HZB YouTube channel how protein crystallography works. All important information about the SARS-CoV-2 research at BESSY II can be found here.
The athlete in the lab coat
Steve Albrecht is researching on perovskite solar cells and holds several efficiency world records with his team. Back in his schooldays, he was going to become either a competitive gymnast or a scientist. He chose science, but the same athletic ambition still drives his research forward.
The route to BESSY III
At HZB we have the experts for designing and building a new accelerator source, and we have many creative scientists onboard, who are making advancements in the development of photon research. The new source BESSY III is planned go into operation in 2030. Our aim is to offer worldwide unique experiments that will accelerate the gaining of new insights in many disciplines.
Patients with eye tumours are being treated with proton beams since June 1998 by the Charité Universitätsklinikum Benjamin Franklin together with the Helmholtz-Zentrum Berlin. Especially, we succeed to destroy the tumour in more than 97 percent of the patients. Eye tumour therapy with protons